Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies.
<h4>Background</h4>There is no consensus regarding whether androgen deprivation therapy (ADT) is associated with cardiovascular disease (CVD) and cardiovascular mortality (CVM). The objective of this study was to determine the role of ADT for prostate cancer (PCa) in development of cardi...
Saved in:
Main Authors: | Jinsheng Zhao, Shimiao Zhu, Libin Sun, Fanzheng Meng, Lin Zhao, Yusheng Zhao, Hao Tian, Ping Li, Yuanjie Niu |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/6265110f975f4b87b51bca948d514168 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells.
by: Dominick G A Burton, et al.
Published: (2013) -
Efficacy and Prognostic Factors of Androgen Deprivation Therapy Combined with Radiation Therapy for Prostate Cancer
by: Siping Zeng, et al.
Published: (2021) -
Metabolic changes in patients with prostate cancer with androgen deprivation therapy
by: Maxim N. Peshkov, et al.
Published: (2020) -
Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.
by: Rolf Gedeborg, et al.
Published: (2021) -
Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
by: Mateus Bringel Oliveira Duarte, et al.
Published: (2021)